#ClinicalPharmacist #PharmD #DrugSpotlight #TRUTAKNA #Atacicept #IgAN #IgANephropathy #Nephrology #KidneyDisease #ClinicalPharmacy #MedicationSafety #EvidenceBasedMedicine #HospitalPharmacy #PatientCare To view or add a comment, sign in Eli Lilly's Retatrutide Advances Toward FDA Submission A major milestone in obesity treatment as Retatrutide (LY3437943) continues to demonstrate impressive Phase 3 results
A new wave of GLP-1 medications looms over the horizon
For one thing, it hasn't yet been established whether taurine supplementation would have the same benefits in humans, and it may have some risks
Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics
Persistent or worsening fatigue despite treatment warrants medical review to investigate other potential causes such as anaemia, thyroid disorders, sleep apnoea, depression, or medication side effects
After receiving his MD from Mount Sinai School of Medicine, he completed his residency in Medicine at the Columbia Presbyterian Medical Center, as well as a fellowship in Oncology at the Memorial Sloan Kettering Cancer Center and a fellowship in Hematology at Weill Cornell Medical College